Target intelligence / Profile preview

Pattern recognition receptors sensing Ad26 vector components (Ad26 PRRs)

Target
Ad26 PRRs
Molecular classification
Pattern recognition receptor, Toll-like receptor, Cytosolic DNA sensor, Inflammasome
01

Overview

Pattern recognition receptors (PRRs) sensing Ad26 vector components represent the host's innate immune machinery responsible for detecting Adenovirus serotype 26 (Ad26) vaccine vectors. This collective target includes endosomal sensors like Toll-like receptor 9 (TLR9), which detects viral DNA, and cytosolic sensors such as cyclic GMP-AMP synthase (cGAS) and the Stimulator of Interferon Genes (STING) (Lam et al., 2014). Additionally, surface receptors like TLR2 may recognize viral capsid proteins, while the NLRP3 inflammasome can be activated by the internalizing vector. The primary biological function of these PRRs is to initiate the innate immune response, characterized by the secretion of Type I interferons and pro-inflammatory cytokines like IL-6 and TNF-alpha. This early activation is crucial for the subsequent development of protective T-cell and B-cell mediated immunity (Teijaro & Farber, 2021). However, the intensity of this sensing must be carefully balanced, as excessive activation is linked to systemic side effects and rare but serious complications like thrombosis with thrombocytopenia syndrome (TTS) (Greinacher et al., 2021). Consequently, these PRRs are key focal points for biotech analysts evaluating the immunogenicity and safety profiles of Ad26-based vaccine platforms.

Other names
Ad26 innate sensorsAdenovirus 26 pattern recognition receptorsInnate immune sensors of Ad26Ad26-sensing PRRs
02

Mechanism of action

Activation of multiple innate immune sensing pathways including TLR9, cGAS-STING, and TLR2 to induce Type I interferons and pro-inflammatory cytokines.

03

Biological functions

Innate immune responseSignal transductionType I interferon productionPro-inflammatory cytokine production
04

Disease associations

InfectionVaccine responseInflammation
05

Safety considerations

Thrombosis with thrombocytopenia syndrome (TTS)Cytokine release syndromeInjection site reactionSystemic inflammatory response
06

Interacting drugs

Ad26.COV2.S (Janssen COVID-19 Vaccine)

4 more in the full profile.

07

Biomarkers

Interferon-alphaInterferon-betaInterleukin-6CXCL10 (IP-10)CCL2 (MCP-1)

Beyond the preview

Go deeper on Pattern recognition receptors sensing Ad26 vector components (Ad26 PRRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern recognition receptors sensing Ad26 vector components (Ad26 PRRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call